BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22917893)

  • 1. CK2 and the regulation of the carbohydrate metabolism.
    Al Quobaili F; Montenarh M
    Metabolism; 2012 Nov; 61(11):1512-7. PubMed ID: 22917893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular regulators of protein kinase CK2.
    Montenarh M
    Cell Tissue Res; 2010 Nov; 342(2):139-46. PubMed ID: 20976471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo assays of protein kinase CK2 activity.
    Prudent R; Sautel CF; Moucadel V; Laudet B; Filhol O; Cochet C
    Methods Enzymol; 2010; 485():597-610. PubMed ID: 21050938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein Kinase II: an attractive target for anti-cancer drug design.
    Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of protein kinase CK2 as oncological target.
    Seeber S; Issinger OG; Holm T; Kristensen LP; Guerra B
    Apoptosis; 2005 Aug; 10(4):875-85. PubMed ID: 16133877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Order or chaos? An evaluation of the regulation of protein kinase CK2.
    Olsten ME; Litchfield DW
    Biochem Cell Biol; 2004 Dec; 82(6):681-93. PubMed ID: 15674436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of the constitutive activity of protein kinase CK2.
    Olsen BB; Guerra B; Niefind K; Issinger OG
    Methods Enzymol; 2010; 484():515-29. PubMed ID: 21036248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.
    Litchfield DW
    Biochem J; 2003 Jan; 369(Pt 1):1-15. PubMed ID: 12396231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells.
    Ahmad KA; Wang G; Ahmed K
    Mol Cancer Res; 2006 May; 4(5):331-8. PubMed ID: 16687488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase CK2 as a druggable target.
    Sarno S; Pinna LA
    Mol Biosyst; 2008 Sep; 4(9):889-94. PubMed ID: 18704226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK2 activity is modulated by growth rate in Saccharomyces cerevisiae.
    Tripodi F; Cirulli C; Reghellin V; Marin O; Brambilla L; Schiappelli MP; Porro D; Vanoni M; Alberghina L; Coccetti P
    Biochem Biophys Res Commun; 2010 Jul; 398(1):44-50. PubMed ID: 20599749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CK2 signaling in androgen-dependent and -independent prostate cancer.
    Wang G; Ahmad KA; Unger G; Slaton JW; Ahmed K
    J Cell Biochem; 2006 Oct; 99(2):382-91. PubMed ID: 16598768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
    Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
    Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase CK2: a newcomer in the 'druggable kinome'.
    Pagano MA; Cesaro L; Meggio F; Pinna LA
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1303-6. PubMed ID: 17073807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In CK2 inactivated cells the cyclin dependent kinase inhibitor Sic1 is involved in cell-cycle arrest before the onset of S phase.
    Tripodi F; Zinzalla V; Vanoni M; Alberghina L; Coccetti P
    Biochem Biophys Res Commun; 2007 Aug; 359(4):921-7. PubMed ID: 17574209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle dependent regulation of protein kinase CK2 signaling to the nuclear matrix.
    Wang H; Yu S; Davis AT; Ahmed K
    J Cell Biochem; 2003 Mar; 88(4):812-22. PubMed ID: 12577315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling.
    Heiker JT; Wottawah CM; Juhl C; Kosel D; Mörl K; Beck-Sickinger AG
    Cell Signal; 2009 Jun; 21(6):936-42. PubMed ID: 19233263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase CK2 is a constitutively active enzyme that promotes cell survival: strategies to identify CK2 substrates and manipulate its activity in mammalian cells.
    Turowec JP; Duncan JS; French AC; Gyenis L; St Denis NA; Vilk G; Litchfield DW
    Methods Enzymol; 2010; 484():471-93. PubMed ID: 21036246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
    Schneider CC; Hessenauer A; Montenarh M; Götz C
    Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.